We Can Medicines Co (ROCO:6929) Beneish M-Score: -2.91 (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6929 We Can Medicines Co Ltd ROCO:6929
46 GF Score
Price NT$22.30
GF Value NT$40.73
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is We Can Medicines Co Beneish M-Score?

We Can Medicines Co ROCO:6929 -0.45% 46 Beneish M-Score is -2.91 as of Jul. 14, 2026. GuruFocus rates ROCO:6929 with a GF Score™ of 46/100 and a GF Value™ of NT$40.73 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,851 Consumer Packaged Goods companies, We Can Medicines Co ranks better than 78.93% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.91 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for We Can Medicines Co's Beneish M-Score or its related term are showing as below:

ROCO:6929' s Beneish M-Score Range Over the Past 10 Years
Min: -3.11   Med: -2.91   Max: -2.02
Current: -2.91

During the past 6 years, the highest Beneish M-Score of We Can Medicines Co was -2.02. The lowest was -3.11. And the median was -2.91.


We Can Medicines Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for We Can Medicines Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

We Can Medicines Co Beneish M-Score Chart

We Can Medicines Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 0.00 -2.02 -3.11 -2.91

We Can Medicines Co Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.11 -3.10 -3.25 -3.24 -2.91

ROCO:6929 vs KHC, GIS: Beneish M-Score Comparison

For the Packaged Foods subindustry, We Can Medicines Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


We Can Medicines Co Beneish M-Score vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, We Can Medicines Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where We Can Medicines Co's Beneish M-Score falls into.


ROCO:6929
46GF Score
We Can Medicines Co Ltd ROCO:6929
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

We Can Medicines Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of We Can Medicines Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0942+0.528 * 1.0186+0.404 * 0.9859+0.892 * 0.9855+0.115 * 0.9236
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9986+4.679 * -0.105175-0.327 * 1.016
=-2.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$234 Mil.
Revenue was 817.542 + 789.549 + 816.84 + 797.872 = NT$3,222 Mil.
Gross Profit was 260.643 + 263.583 + 274.236 + 269.579 = NT$1,068 Mil.
Total Current Assets was NT$1,450 Mil.
Total Assets was NT$2,978 Mil.
Property, Plant and Equipment(Net PPE) was NT$1,473 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$321 Mil.
Selling, General, & Admin. Expense(SGA) was NT$1,136 Mil.
Total Current Liabilities was NT$948 Mil.
Long-Term Debt & Capital Lease Obligation was NT$937 Mil.
Net Income was -27.886 + -26.241 + -6.66 + -12.425 = NT$-73 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = NT$0 Mil.
Cash Flow from Operations was 81.968 + 54.011 + 73.811 + 30.233 = NT$240 Mil.
Total Receivables was NT$217 Mil.
Revenue was 814.642 + 812.587 + 823.878 + 818.097 = NT$3,269 Mil.
Gross Profit was 261.014 + 269.211 + 278.266 + 295.419 = NT$1,104 Mil.
Total Current Assets was NT$1,465 Mil.
Total Assets was NT$3,086 Mil.
Property, Plant and Equipment(Net PPE) was NT$1,562 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$309 Mil.
Selling, General, & Admin. Expense(SGA) was NT$1,154 Mil.
Total Current Liabilities was NT$921 Mil.
Long-Term Debt & Capital Lease Obligation was NT$1,001 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(233.919 / 3221.803) / (216.918 / 3269.204)
=0.072605 / 0.066352
=1.0942

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(1103.91 / 3269.204) / (1068.041 / 3221.803)
=0.337669 / 0.331504
=1.0186

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1449.674 + 1472.537) / 2978.217) / (1 - (1464.623 + 1562.118) / 3085.594)
=0.018805 / 0.019073
=0.9859

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3221.803 / 3269.204
=0.9855

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(309.08 / (309.08 + 1562.118)) / (320.705 / (320.705 + 1472.537))
=0.165178 / 0.178841
=0.9236

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1135.765 / 3221.803) / (1154.039 / 3269.204)
=0.352525 / 0.353003
=0.9986

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((937.137 + 947.86) / 2978.217) / ((1000.762 + 921.387) / 3085.594)
=0.632928 / 0.622943
=1.016

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-73.212 - 0 - 240.023) / 2978.217
=-0.105175

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

We Can Medicines Co has a M-score of -2.91 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.91 mean?
We Can Medicines Co (ROCO:6929) has a Beneish M-Score of -2.91 as of Jul. 14, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on We Can Medicines Co and its competitors. According to the industry distribution chart, We Can Medicines Co ranks #390 out of 1851 companies in the Consumer Packaged Goods industry, placing it in the top 21.1%.
Is We Can Medicines Co's Beneish M-Score too high?
We Can Medicines Co's current Beneish M-Score is -2.91. Based on the distribution chart, We Can Medicines Co ranks #390 out of 1851 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, We Can Medicines Co has a GF Score™ of 46/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does We Can Medicines Co's Beneish M-Score compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, We Can Medicines Co ranks #390 out of 1851 companies for Beneish M-Score. This places We Can Medicines Co in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Consumer Packaged Goods company?
A good Beneish M-Score depends on the Consumer Packaged Goods industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on We Can Medicines Co and its competitors. We Can Medicines Co's current Beneish M-Score is -2.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is We Can Medicines Co stock overvalued right now?
Based on GuruFocus' analysis, We Can Medicines Co (ROCO:6929) is currently considered Possible Value Trap. The stock's GF Value™ is NT$40.73, compared to a current price of NT$22.30 — trading 45.2% below its estimated fair value. The current Beneish M-Score is -2.91. We Can Medicines Co's overall GF Score™ is 46/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For We Can Medicines Co (ROCO:6929), the current Beneish M-Score is -2.91 as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is We Can Medicines Co (ROCO:6929) Overvalued in 2026?

Based on GuruFocus' analysis, We Can Medicines Co stock appears to be undervalued. The current stock price of NT$22.30 is trading 45.2% below its estimated GF Value™ of NT$40.73. GuruFocus considers We Can Medicines Co to be Possible Value Trap.

Key valuation signals for ROCO:6929:

  • Beneish M-Score: -2.91
  • GF Value™: NT$40.73 vs. price of NT$22.30 (45.2% below fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the ROCO:6929 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


We Can Medicines Co Business Description

Address Section 4, Taiwan Avenue, 20th Floor-1, No. 925, Xitun District, Taichung, TWN
We Can Medicines Co Ltd is a Taiwan-based company mainly engaged in the operation of chain cosmeceutical drugstores. The Company's main products include pharmaceuticals and health food, maternity and infant products, medical supplies, beauty cosmetics, and daily necessities.
46GF Score

Get the complete analysis for ROCO:6929

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.30
Price
NT$40.73
GF Value